Profiel
Jarvis Reagan is associated with Anocca AB, where he is the Chief Executive Officer & Director.
He founded Anocca AB in 2014.
Actieve functies van Jarvis Reagan
| Bedrijven | Functie | Begin |
|---|---|---|
Anocca AB
 Anocca AB Miscellaneous Commercial ServicesCommercial Services Anocca AB is a Swedish biopharmaceutical company that is developing next-generation T-cell immunotherapies for the treatment of solid tumors, autoimmune diseases, and infectious diseases. The company was founded in 2014 by Jarvis Reagan and is based in Sweden. The company is building libraries of novel T-cell immunotherapies that specifically target difficult-to-treat cancers and will be moving into clinical trials in 2024. Anocca has a fully integrated research and development infrastructure, underpinned by tailor-made advanced software solutions and in-house clinical manufacturing and process development facilities. Anocca has raised over USD 100 million in funding from leading Nordic investors and secured EUR 25 million in funding from the European Investment Bank in 2022. The company's team of over 90 employees operates from its state-of-the-art R&D and manufacturing facilities. Jarvis Reagan has been the CEO since 2014. | Oprichter | 01-01-2014 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Anocca AB
Anocca AB Miscellaneous Commercial ServicesCommercial Services Anocca AB is a Swedish biopharmaceutical company that is developing next-generation T-cell immunotherapies for the treatment of solid tumors, autoimmune diseases, and infectious diseases. The company was founded in 2014 by Jarvis Reagan and is based in Sweden. The company is building libraries of novel T-cell immunotherapies that specifically target difficult-to-treat cancers and will be moving into clinical trials in 2024. Anocca has a fully integrated research and development infrastructure, underpinned by tailor-made advanced software solutions and in-house clinical manufacturing and process development facilities. Anocca has raised over USD 100 million in funding from leading Nordic investors and secured EUR 25 million in funding from the European Investment Bank in 2022. The company's team of over 90 employees operates from its state-of-the-art R&D and manufacturing facilities. Jarvis Reagan has been the CEO since 2014. | Commercial Services |
